Search
Now showing items 1-10 of 134
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction
(LIPPINCOTT WILLIAMS & WILKINSPHILADELPHIA, 2012)
Objectives Predictors of adverse outcomes following myocardial infarction (MI) are well established; however, little is known about what predicts enzymatically estimated infarct size in patients with acute ST-elevation MI. ...
Adjunctive Thrombectomy in Primary Percutaneous Intervention for Acute Myocardial Infarction
(Arquivos Brasileiros CardiologiaRio De JaneiroBrasil, 2011)
In-hospital mortality after ST-segment elevation myocardial infarction according to reperfusion therapy Mortalidad intrahospitalaria en hombres y mujeres según terapias de reperfusión en infarto agudo del miocardio con supradesnivel del ST
(Sociedad Medica de Santiago, 2008)
Background: Primary angioplasty is considered the best reperfusion therapy in the treatment of ST-segment elevation myocardial infarction (STEMI). However, thrombolysis is the reperfusion method most commonly used, due to ...
Effect of pharmacological treatment on cardiac biomarkers in patients with acute coronary syndrome of non–ST segment elevation with Type-2 diabetes
(IJMHS, 2016-01)
The acute coronary syndrome is a consequence of coronary artery disease. Creatine Kinase MB is a cardiac biochemical marker used in the diagnosis and risk stratification of patients. The diabetes is a pathology associated ...
Fondaparinux em intervenção coronária percutânea no tratamento da síndrome coronária aguda
(2012-06-01)
Background: Fondaparinux is considered an agent with a well-established safety and efficacy profile in the treatment of non-ST segment elevation acute coronary syndromes, but when used alone, is associated to a higher ...
Admission hyperglycemia and mortality of st segment elevation myocardial infarction Implicancias de la glicemia de ingreso en la mortalidad intrahospitalaria y alejada según el método de reperfusión en pacientes con infarto agudo del miocardio y supradesn
(2010)
Background: Hyperglycemia at admission has been associated to an adverse prognosis in patients with ST-segment elevation acute myocardial infarction (STEMI). However, its impact over the results of reperfusion therapies ...